Clinical Trials Browser

Phase 1/2 × INDUSTRY × Advanced Biliary Tract Cancer × Clear all

NCT05653180 2023-04-03

IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer

Phase 1/2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer